E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/17/2013 in the Prospect News PIPE Daily.

Edwards Lifesciences completes $5 million private placement of shares

Deal sells 70,283 shares at $71.14 per share to Mussallem Living Trust

By Devika Patel

Knoxville, Tenn., May 17 - Edwards Lifesciences Corp. settled a $5 million private placement of stock with the Mussallem Living Trust on May 15, according to an 8-K filed Friday with the Securities and Exchange Commission. The deal priced on May 13.

The company sold 70,283 common shares at $71.14 per share. The price per share is a 4.82% premium to the $67.87 closing share price on May 10.

The Irvine, Calif., company focuses on providing products and technologies to address cardiovascular disease.

Issuer:Edwards Lifesciences Corp.
Issue:Common stock
Amount:$5 million
Shares:70,283
Price:$71.14
Warrants:No
Investor:Mussallem Living Trust
Pricing date:May 13
Settlement date:May 15
Stock symbol:NYSE: EW
Stock price:$67.87 at close May 10
Market capitalization:$7.62 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.